Cambridge Nucleomics Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Angel

  • Investors
  • 8

Cambridge Nucleomics General Information

Description

Developer of a biotechnology platform designed to enable fast and direct quantification of native RNA molecules. The company's platform digitizes RNA measurement with single-molecule accuracy, providing high-multiplexed, enzyme-free detection that enhances RNA quantification, diagnostics, and drug discovery, enabling pharmaceutical and clinical researchers to achieve precise and scalable insights for personalized medicine.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • Ketton Suite King Centre, Main Road
  • Barleythorpe, Oakham
  • Rutland LE15 7WD
  • England, United Kingdom
Primary Industry
Other Healthcare Technology Systems
Other Industries
Biotechnology
Pharmaceuticals
Corporate Office
  • Ketton Suite King Centre, Main Road
  • Barleythorpe, Oakham
  • Rutland LE15 7WD
  • England, United Kingdom

Cambridge Nucleomics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cambridge Nucleomics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Angel (individual) 01-May-2025 Completed Generating Revenue
8. Grant 01-Feb-2024 Completed Generating Revenue
7. Accelerator/Incubator 27-Apr-2023 Completed Generating Revenue
6. Accelerator/Incubator 27-Apr-2023 Completed Generating Revenue
5. Accelerator/Incubator 23-Mar-2022 Completed Generating Revenue
4. Accelerator/Incubator 01-Jan-2022 Completed Generating Revenue
3. Accelerator/Incubator 01-Sep-2021 Completed Generating Revenue
2. Accelerator/Incubator 01-Jan-2021 Completed Generating Revenue
1. University Spin-Out 01-Jan-2021 Completed Generating Revenue
To view Cambridge Nucleomics’s complete valuation and funding history, request access »

Cambridge Nucleomics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cambridge Nucleomics Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Cambridge Angels Angel Group Minority
Trinity Bradfield Corporation
Berkeley SkyDeck Accelerator/Incubator
Factory Plus Accelerator/Incubator Minority
Cancer Tech Accelerator Accelerator/Incubator
You’re viewing 5 of 8 investors. Get the full list »

Cambridge Nucleomics FAQs

  • When was Cambridge Nucleomics founded?

    Cambridge Nucleomics was founded in 2021.

  • Where is Cambridge Nucleomics headquartered?

    Cambridge Nucleomics is headquartered in Rutland, United Kingdom.

  • What is the size of Cambridge Nucleomics?

    Cambridge Nucleomics has 7 total employees.

  • What industry is Cambridge Nucleomics in?

    Cambridge Nucleomics’s primary industry is Other Healthcare Technology Systems.

  • Is Cambridge Nucleomics a private or public company?

    Cambridge Nucleomics is a Private company.

  • What is Cambridge Nucleomics’s current revenue?

    The current revenue for Cambridge Nucleomics is .

  • How much funding has Cambridge Nucleomics raised over time?

    Cambridge Nucleomics has raised $341K.

  • Who are Cambridge Nucleomics’s investors?

    Cambridge Angels, Trinity Bradfield, Berkeley SkyDeck, Factory Plus, and Cancer Tech Accelerator are 5 of 8 investors who have invested in Cambridge Nucleomics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process